Activation of Mesangial Cells by the Phosphatase Inhibitor Vanadate: Potential Implications for Diabetic Nephropathy

Journal of Clinical Investigation

Volumn 95, Issue 3, 1995, Pages 1244-1252

  Wenzel, Ulrich O ^b   Fouqueray, Bruno ^b   Biswas, Purba ^b   Grandaliano, Giuseppe ^b   Choudhury, Goutam Ghosh ^b   Abboud, Hanna E ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NONE

Author keywords

Human kidney; Phospholipase C; Platelet derived growth factor; Protein kinase C; Tyrosine phosphorylation

Indexed keywords

CALCIUM ION; DNA; GENISTEIN; GLUCOSE; HERBIMYCIN A; INSULIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATASE; PHOSPHATASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VANADIC ACID;

ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA SYNTHESIS; DOSE TIME EFFECT RELATION; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INSULIN LIKE ACTIVITY; MESANGIUM CELL; MITOGENESIS; PRIORITY JOURNAL;

CALCIUM; DIABETIC NEPHROPATHIES; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GLOMERULAR MESANGIUM; HUMAN; INOSITOL PHOSPHATES; MITOGENS; PHOSPHOLIPASE C; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PROTEIN KINASE C; PROTEIN-TYROSINE-PHOSPHATASE; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TETRADECANOYLPHORBOL ACETATE; TYROSINE; VANADATES;

EID: 0028940933     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI117774     Document Type: Article

References (50)

1. Heyliger, C. E., A. G. Tahiliani, and T. H. McNeil. 1985. Effect of vanadate on elevated blood glucose and depressed cardiac performance in diabetic rats. Science (Wash. DC). 227:1474-1476.
2. Meyerovitch, J., P. Rothenberg, Y. Shechter, S. Bonner-Weir, and C. R. Kahn. 1991. Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus. J. Clin. Invest. 87:1286-1294.
3. Michael, F., M. F. Cicirelli, N. K. Tonks, C. D. Diltz, J. E. Weiel, E. H. Fisher, and E. G. Krebs. 1990. Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes. Proc. Natl. Acad. Sci. USA. 87:5514-5518.
4. Mauer, M. 1994. Structural-functional correlations of diabetic nephropathy. Kidney Int. 45:612-622.
5. Young, B., R. Johnson, C. Alpers, E. Eng, J. Floege, and W. Couser. 1992. Mesangial cell proliferation precedes development of glomerulosclerosis in experimental diabetic nephropathy. J. Am. Soc. Nephrol. 3:770a. (Abstr.)
6. Abboud, H. E. 1992. Growth factors and the mesangium. J. Am. Soc. Nephrol. 2:S185-S189.
7. Montesano, R., M. S. Pepper, P. Belin, J. D. Vassalli, and L. Orci. 1988. Induction of angiogenesis in vitro by vanadate, an inhibitor of phosphotyrosine phosphatases. J. Cell. Physiol. 134:460-466.
8. Canalis, E. 1985. Effect of sodium vanadate on deoxyribonucleic acid and protein synthesis in cultured rat calvariae. Endocrinology. 116:855-862.
9. Smith, J. B. 1983. Vanadium ions stimulate DNA synthesis in Swiss mouse 3T3 and 3T6 cells. Proc. Natl. Acad. Sci. USA. 80:6162-6166.
10. Maher, P. A. 1992. Stimulation of endothelial cell proliferation by vanadate is specific for microvascular endothelial cells. J. Cell. Physiol. 151:549-554.
11. 3H1 cells by fibroblast growth factor and vanadate. J. Biol. Chem. 262:1810-1817.
12. Rawson, C., C. Cosola-Smith, and D. Barnes. 1990. Death of serum-free mouse embryo cells caused by epidermal growth factor deprivation is prevented by cycloheximide, 12-O-tetradecanoylphorbol-13-acetate, or vanadate. Exp. Cell Res. 186:77-181.
13. Heldin, C. H., T. Asplund, D. Ytterberg, and S. Thein. 1992. Characterization of the molecular mechanism involved in the deprivation of hyaluronan synthetase in platelet-derived growth factor in human mesothelial cells. Biochem. J. 283:165-170.
14. Shultz, P. G., P. E. DiCorleto, B. G. Silver, and H. E. Abboud. 1988. Mesangial cells express PDGF mRNAs and proliferate in response to PDGF. Am. J. Physiol. 255:F674-F684.
15. Akiyama, T., and H. Ogawara. 1991. Use and specifity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol. 201:362-369.
16. Ueharay, Y., and H. Fuhazawa. 1991. Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases. Methods Enzymol. 201:370-379.
17. Jaffer, F., C. Saunders, P. Schultz, D. Throck-Morton, E. Winshell, and H. E. Abboud. 1989. Regulation of mesangial cell growth by polypeptide mitogens. Inhibiting role of transforming growth factor beta. Am. J. Pathol. 135:261-269.
18. Knauss, T. C., F. E. Jaffer, and H. E. Abboud. 1990. Phosphatidic acid modulates DNA synthesis, phospholipase C and platelet derived growth factor mRNAs in cultured mesangial cells. Role of protein kinase C. J. Biol. Chem. 265:14457-14463.
19. Streuli, M., N. X. Krueger, T. Thai, M. Tang, and H. Saito. 1990. Distinct functional roles of the two intracellular phosphatase like domains of the receptor linked protein tyrosine phosphatases LCA and LAR. EMBO (Eur. Mol. Biol. Org.) J. 9:2399-2407.
20. Ghosh Choudhury, G., V. L. Sylvia, L. M. Wang, T. Pierce, and A. Y. Sahaguchi. 1991. The kinase insert domain of colony stimulating factor-1 receptor is dispensable for CSF-1 induced phosphatidylcholine hydrolysis. FEBS (Fed. Eur. Biochem. Soc.) Lett. 282:351-354.
21. Grandaliano, G., P. Biswas, G. Ghosh Choudhury, and H. E. Abboud. 1993. Simvastatin inhibits PDGF-induced DNA synthesis in human mesangial cells. Kidney Int. 44:503-508.
22. ++ indicator with greatly improved fluorescence properties. J. Biol. Chem. 260:3440-3450.
23. Ghosh Choudhury, G., P. Biswas, G. Grandaliano, and H. E. Abboud. 1993. Involvement of protein kinase C in platelet-derived growth factor-mediated mitogenic signalling in human glomerular mesangial cells. Am. J. Physiol. 265:F634-F642.
24. Bell, R. M., Y. Hannun, and C. Loomis. 1986. Mixed micelle assay of protein kinase C. Methods Enzymol. 124:353-359.
25. Yasuda, I., A. Kishimoto, S. Tanaka, M. Tominaga, A. Sakurai, and Y. Nishizuka. 1990. A synthetic peptide substrate for selective assay of protein kinase C. Biochem. Biophys. Res. Commun. 166:1220-1227.
26. v-src kinase activity by vanadate in intact cells accompanies a new phosphorylation state of the enzyme. J. Biol. Chem. 259:9580-9586.
27. Tamura, S., T. A. Brown, J. H. Whipple, Y. Fujita-Yamaguchi, R. E. Dubler, K. Cheng, and J. Larner. 1984. A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. J. Biol. Chem. 259:6650-6658.
28. Silver, B. G., F. E. Jaffer, and H. E. Abboud. 1989. Platelet derived growth factor (PDGF) synthesis in mesangial cells: induction by multiple peptide mitogens. Proc. Natl. Acad. Sci. USA. 86:1056-1060.
29. Abboud, H. E., G. Grandaliano, M. Pinzani, T. Knauss, G. F. Pierce, and F. Jaffer. 1994. Action of platelet-derived growth factor isoforms in mesangial cells. J. Cell. Physiol. 158:140-150.
30. Escobedo, J. A., and L. T. Williams. 1988. A PDGF receptor domain essential for mitogenesis but not for many other responses to PDGF. Nature (Lond.). 335:85-87.
31. Shechter, Y. 1990. Insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes. Diabetes. 39:1-5.
32. Cros, G., J. J. Mongold, J. J. Serrano, S. Ramanadham, and J. H. McNeill. 1992. Effects of vanadyl derivatives on animal models of diabetes. Mol. Cell. Biochem. 109:163-166.
33. Bosch, F., M. Hatzoglou, E. A. Park, and R. W. Hanson. 1990. Vanadate inhibits expression of the gene for phosphoenolpyruvate carboxykinase (GTP) in rat hepatoma cells. J. Biol. Chem. 265:13677-13682.
34. Wu, Y. Y., and R. A. Bradshaw. 1993. Effect of nerve growth factor and fibroblast growth factor on PC12 cells: inhibition by orthovanadate. J. Cell Biol. 121:409-422.
35. Klarlund, J. K. 1985. Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins. Cell. 41:707-717.
36. Saxena, A. K., P. Srivastava, R. K. Kale, and N. Z. Baquer. 1992. Effect of vanadate administration on polyol pathway in diabetic rat kidney. Biochem. Int. 26:59-68.
37. Fischer, E. H., H. Charbonneau, and N. K. Tonks. 1991. Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science (Wash. DC). 253:401-406.
38. Grandaliano, G., G. Ghosh Choudhury, P. Biswas, and H. E. Abboud. Mitogenic signalling of thrombin in mesangial cell: role of tyrosine phosphorylation. Am. J. Physiol. 267:F528-F536.
39. Ghosh Choudhury, G., P. Biswas, G. Grandaliano, B. Fouqueray, S. A. Harvey, and H. E. Abboud. 1994. PDGF-mediated activation of phosphatidylinositol 3 kinase in human mesangial cells. Kidney Int. 46:37-47.
40. Huang, C. L., and H. E. Ives. 1987. Growth inhibition by protein kinase C late in mitogenesis. Nature (Lond.). 329:847-850.
41. +)-ATPase inhibitor. J. Biol. Chem. 255:5306-5312.
42. Nechay, B. R. 1984. Mechanisms of action of vanadate. Annu. Rev. Pharmacol. Toxicol. 24:501-524.
43. Striker, G. E., E. P. Peten, M. A. Carome, C. M. Pesce, K. Schmidt, C. W. Yang, S. J. Elliott, and L. J. Striker. 1993. The kidney disease of diabetes mellitus (KDDM): a cell and molecular biology approach. Diabetes Metab. Rev. 9:37-56.
44. Sharma, K., and F. N. Ziyadeh. 1993. The transforming growth factor-beta system and the kidney. Semin. Nephrol. 13:116-128.
45. Doi, T., H. Vlassara, M. Kirstein, Y. Yamada, G. E. Striker, and L. J. Striker. 1992. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc. Natl. Acad. Sci. USA. 89:2873-2877.
46. Barnes, J. L., and H. E. Abboud. 1993. Temporal expression of autocrine growth factors corresponds to morphological features of mesangial proliferation in habu snake venom induced glomerulonephritis. Am. J. Pathol. 143:1366-1367.
47. Gesualdo, L., M. Pinzani, J. J. Floriano, M. O. Hassan, N. U. Nagy, F. P. Schena, S. N. Emancipator, and H. E. Abboud. 1991. Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Lab. Invest. 64:160-167.
48. Iida, H., R. Seifert, C. E. Alpers, R. G. K. Gronwald, P. E. Phillips, P. Pritzl, K. Gordon, A. M. Gown, R. Ross, D. F. Bowen-Pope, and R. J. Johnson. 1991. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc. Natl. Acad. Sci. USA. 88:6560-6564.
49. Nakamura, T., M. Fukui, I. Ebihara, S. Osada, I. Nagaoka, Y. Tomino, and H. Koide. 1993. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes. 42:450-456.
50. Gherzi, R., C. Caratti, G. Andraghetti, S. Bertolini, A. Montemurro, G. Sesti, and R. Cordera. 1988. Direct modulation of insulin receptor protein tyrosine kinase by vanadate and anti-insulin receptor monoclonal antibodies. Biochem. Biophys. Res. Commun. 152:1474-1480.